BlackRock’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-449,857
| Closed | -$23.8M | – | 5251 |
|
|
2020
Q3 | $23.8M | Sell |
449,857
-1,089
| -0.2% | -$67.2K | ﹤0.01% | 2766 |
|
|
2020
Q2 | $27.6M | Buy |
450,946
+8,472
| +2% | +$490K | ﹤0.01% | 2632 |
|
|
2020
Q1 | $25M | Sell |
442,474
-3,269
| -0.7% | -$186K | ﹤0.01% | 2486 |
|
|
2019
Q4 | $25.4M | Buy |
445,743
+3,417
| +0.8% | +$181K | ﹤0.01% | 2745 |
|
|
2019
Q3 | $23.7M | Buy |
442,326
+13,781
| +3% | +$802K | ﹤0.01% | 2722 |
|
|
2019
Q2 | $25.6M | Buy |
428,545
+23,007
| +6% | +$1.45M | ﹤0.01% | 2705 |
|
|
2019
Q1 | $25.3M | Sell |
405,538
-108,419
| -21% | -$7.17M | ﹤0.01% | 2631 |
|
|
2018
Q4 | $31.1M | Buy |
513,957
+26,808
| +6% | +$1.6M | ﹤0.01% | 2492 |
|
|
2018
Q3 | $28.5M | Buy |
487,149
+82,625
| +20% | +$4.22M | ﹤0.01% | 2686 |
|
|
2018
Q2 | $18.1M | Buy |
404,524
+81,981
| +25% | +$3.53M | ﹤0.01% | 2915 |
|
|
2018
Q1 | $14.3M | Sell |
322,543
-49,042
| -13% | -$2.06M | ﹤0.01% | 2944 |
|
|
2017
Q4 | $16.1M | Sell |
371,585
-15,324
| -4% | -$689K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $18M | Buy |
386,909
+4,539
| +1% | +$217K | ﹤0.01% | 2864 |
|
|
2017
Q2 | $18.9M | Buy |
382,370
+4,214
| +1% | +$221K | ﹤0.01% | 2818 |
|
|
2017
Q1 | $20.7M | Buy |
378,156
+377,759
| +95,153% | +$20M | ﹤0.01% | 2735 |
|
|
2016
Q4 | $22K | Sell |
397
-586
| -60% | -$28.2K | ﹤0.01% | 3236 |
|
|
2016
Q3 | $45K | Sell |
983
-192
| -16% | -$7.71K | ﹤0.01% | 3016 |
|
|
2016
Q2 | $47K | Buy |
1,175
+986
| +522% | +$36.1K | ﹤0.01% | 2972 |
|
|
2016
Q1 | $7K | Sell |
189
-11
| -6% | -$404 | ﹤0.01% | 3297 |
|
|
2015
Q4 | $9K | Sell |
200
-100
| -33% | -$5.01K | ﹤0.01% | 2949 |
|
|
2015
Q3 | $13K | Buy |
+300
| New | +$16.2K | ﹤0.01% | 2622 |
|
Other funds holding BSTC
BlackRock's BSTC Position: Q4 2020 in Review
BlackRock sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 449,857 shares — an estimated $23.8M sold.
BlackRock first reported a position in BSTC in Q3 2015 and held it in 21 quarters. The position peaked at $31.1M in Q4 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- BlackRock reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- BlackRock sold 449,857 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $23.8M.
- BlackRock first reported a position in BioSpecifics Technologies Corp. in Q3 2015 and held it in 21 quarters.
- BlackRock's BioSpecifics Technologies Corp. position peaked at $31.1M in Q4 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.